# Varex Imaging Corporation (VREX) Stock Analysis: Exploring a 65.92% Potential Upside in the Medical Devices Sector

- Link: https://www.directorstalkinterviews.com/varex-imaging-corporation-vrex-stock-analysis-exploring-a-65-92-potential-upside-in-the-medical-devices-sector/4121245299
- Published: 2026-03-19T11:10:43+00:00
- Author: Madison Wilson

Varex Imaging Corporation (NASDAQ: VREX) stands out in the healthcare sector, specifically
within the medical devices industry, by offering a comprehensive range of X-ray 
imaging components for both medical and industrial applications. With a market capitalization
of $464.89 million, Varex serves a global clientele, extending its footprint across
North America, Latin America, Europe, the Middle East, India, Africa, Asia, and 
Australia.

Recently trading at $11.09, Varex’s current stock price reflects a slight decline
of 0.25 (-0.02%), yet it remains within its 52-week range of $6.88 to $14.36. Investors
may find the stock’s forward P/E ratio of 10.87 appealing, indicating a potential
undervaluation compared to industry peers, especially when considering its absence
of a trailing P/E and PEG ratio.

Varex’s performance metrics provide a mixed picture. The company reports a revenue
growth of 4.90%, which is promising in a competitive market. However, its negative
earnings per share (EPS) of -1.64 and a return on equity (ROE) of -12.90% highlight
underlying challenges in profitability and operational efficiency. The company’s
free cash flow stands at -$15.69 million, emphasizing the need for strategic financial
management.

Despite these hurdles, Varex’s future outlook is bolstered by strong analyst confidence.
With four buy ratings and one hold rating, the consensus suggests optimism for a
rebound. The average target price is set at $18.40, with a target price range of
$16.00 to $22.00, indicating a potential upside of 65.92% from its current price.
Such a significant potential increase could be enticing for investors seeking growth
opportunities in the medical devices sector.

From a technical perspective, Varex’s stock exhibits some bearish signals. The 50-
day moving average of $13.14 is above the current price, while the 200-day moving
average is closely aligned at $11.17. The RSI (14) is notably low at 1.40, suggesting
the stock is heavily oversold and possibly primed for a reversal. The MACD of -0.65,
with a signal line of -0.55, further underscores the recent downward momentum.

Varex does not currently offer a dividend, maintaining a payout ratio of 0.00%. 
This approach allows the company to reinvest earnings into growth and innovation—
crucial for maintaining its competitive edge in the rapidly evolving field of medical
imaging technology.

Overall, Varex Imaging Corporation presents a compelling narrative for investors
willing to take on some risk for the prospect of substantial returns. While the 
company faces profitability challenges and operational inefficiencies, its strategic
position in the medical devices industry, combined with strong analyst support and
significant potential upside, make it a stock worth watching closely. As the company
continues to navigate its financial landscape, it holds promise for those with a
long-term investment horizon and an appetite for growth in the healthcare sector.

Share on: